BB BIOTECH AG 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-11 4:34 pm Sale |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BB BIOTECH AG | 0 0.000% |
-2,680,283![]() (Position Closed) |
Filing |
2021-02-12 4:51 pm Unchanged |
2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BB BIOTECH AG | 2,680,283 7.200% |
0 (Unchanged) |
Filing |